IMRX logo

Immuneering Corporation Class A Common Stock


IMRX: Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to leading pharmaceutical and biotechnology companies.


Show IMRX Financials

Consumer Interest
SEC Filings

Recent trades of IMRX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by IMRX's directors and management

Quiver Logo

No recent Insider Trading for this ticker

Insider Trading Dashboard

Government lobbying spending instances

Quiver Logo

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard
U.S. Patents

New patents grants

  • Patent Title: Systems and methods for rapid gene set enrichment analysis Jun. 22, 2021
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of IMRX in WallStreetBets Daily Discussion


Recent insights relating to IMRX

CNBC Recommendations

Recent picks made for IMRX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in IMRX

Corporate Flights

Flights by private jets registered to IMRX